LENSAR (LNSR) CFO exercises options, holds 175,959 shares

Rhea-AI Filing Summary

LENSAR, Inc. Chief Financial Officer Thomas R. Staab II exercised stock options to acquire 5,500 shares of common stock at $2.65 per share. Following the transaction, he directly holds 175,959 shares of LENSAR common stock.

The exercised option is part of a grant that vested 25% on January 11, 2024, with the remainder vesting in thirty-six monthly installments, contingent on continued service. This filing reflects a routine compensation-related option exercise rather than an open-market purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

STAAB THOMAS R II

(Last) (First) (Middle)

2800 DISCOVERY DRIVE

(Street)

ORLANDO FLORIDA 32826

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LENSAR, Inc. [ LNSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		M		5,500	A	$2.65	175,959	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.65	03/19/2026		M			5,500	(1)	01/11/2033	Common Stock	5,500	$0.00	14,295	D

Explanation of Responses:

1. The option vested as to 25% of the award on January 11, 2024 and vests, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

	/s/ Thomas R. Staab, II	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did LENSAR (LNSR) disclose in this Form 4 insider filing?

The filing shows LENSAR’s Chief Financial Officer, Thomas R. Staab II, exercised stock options for 5,500 shares of common stock at $2.65 per share. This is a compensation-related option exercise, not an open-market stock purchase or sale.

How many LENSAR (LNSR) shares does the CFO hold after this transaction?

After exercising options for 5,500 shares, the CFO directly owns 175,959 shares of LENSAR common stock. This updated holding reflects his position following the reported option exercise on March 19, 2026, as disclosed in the Form 4 filing.

What type of transaction did the LENSAR (LNSR) CFO report on this Form 4?

The CFO reported an option exercise, coded “M,” converting a stock option into 5,500 shares of LENSAR common stock at an exercise price of $2.65 per share. No open-market buying or selling activity was reported.

How do the CFO’s LENSAR (LNSR) stock options vest according to the filing?

The option grant vested 25% on January 11, 2024, with the remaining portion vesting in 36 substantially equal monthly installments. Vesting is subject to the CFO’s continued service with LENSAR through each applicable vesting date.

Does the LENSAR (LNSR) Form 4 indicate any stock sales by the CFO?

No stock sales are reported. The Form 4 only shows a derivative exercise, where options were converted into 5,500 common shares at $2.65 each. The filing does not list any open-market dispositions or tax-withholding share transfers.